I just don't agree the reimbursement is quite good in China.
They are spending now to capture the change/reform and expected expansion of healthcare system that had been neglected for years. China's current expenditure on healthcare as percentage of GDP (less than 6%) is in the bottom half among all countries in the world.
It doesn't have to be 5-10 years to get payoff. The payoff will be gradual. If they can get on the formulary, they'll get some payoff due to the size of China. The size of contribution to top and bottom line for most will be small, but growth rate will be very high. For example, Bayer has done quite well in China due to head start.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.